CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT
CytomX Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 41.6M | 31.87M | 13.83M | 11.09M | 16.53M | -569K | -29.36M | -55.65M | -78.74M | -99.32M | -97.59M | -96.88M | -91.94M | -83.61M | -72.08M | -64.21M | -60.64M |
Depreciation & Amortization | 91K | 522K | 595K | 1.9M | 2.05M | 2.17M | 2.3M | 2.44M | 2.44M | 2.44M | 2.51M | 2.57M | 2.63M | 2.71M | 2.69M | 2.67M | 2.61M |
Stock-Based Compensation | 7.77M | 7.67M | 8.34M | 7.57M | 8.06M | 8.56M | 8.58M | 10.04M | 12.16M | 13.13M | 14.1M | 14.57M | 13.5M | 13.17M | 13.04M | 13.72M | 13.81M |
Other Working Capital | -9.32M | -41.49M | -23.28M | -103.8M | -102.66M | -94.48M | -12.41M | -5.22M | 1.4M | 4.47M | -73.3M | -72.69M | -71.91M | -66.21M | -63.15M | -63.7M | -64.74M |
Other Non-Cash Items | -90.13M | -79M | -75.78M | 9.07M | 16.59M | 4.83M | 2.36M | 2.27M | 2.17M | 3.62M | 3.29M | 3.24M | 3.18M | 3.13M | 5.32M | 4.5M | 3.54M |
Deferred Income Tax | n/a | n/a | -4.87M | -6.8M | -8.52M | -8.52M | -3.66M | -1.73M | n/a | n/a | -15K | -9K | 131K | 272K | 287K | 281K | 141K |
Change in Working Capital | -127K | -41.46M | -24.58M | -102.79M | -114.13M | -62.51M | -15.68M | -8.44M | 1.84M | -30.65M | -62.88M | -59.92M | -57.91M | -54.7M | -54.52M | -57.2M | 65.61M |
Operating Cash Flow | -81.23M | -86.23M | -88.29M | -85.8M | -91.43M | -56.03M | -35.47M | -51.07M | -60.13M | -110.79M | -140.59M | -136.44M | -130.4M | -119.03M | -105.27M | -100.24M | 25.06M |
Capital Expenditures | -314K | -310K | -496K | -486K | -907K | -840K | -756K | -1.16M | -1.05M | -1.74M | -1.8M | -1.66M | -1.36M | -1.61M | -1.81M | -2.32M | -2.24M |
Cash Acquisitions | n/a | n/a | -13.13M | 29.8M | -70.2M | -70.2M | -57.07M | -100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -175.28M | -155.49M | -217.57M | -298.19M | -278.24M | -424.83M | -312.97M | -220.04M | -146.59M | n/a | n/a | n/a | -99.9M | -99.9M | -110M | -254.3M | -154.4M |
Sales Maturities Of Investments | 261M | 255.5M | 315.5M | 335M | 320M | 275M | 250M | 200M | 100M | 100M | n/a | 10M | 64M | 124M | 154M | 199.01M | 194.5M |
Other Investing Acitivies | n/a | 45M | 58.13M | 15.2M | 115.2M | -76.39M | 10.48M | 53.41M | -46.59M | 100M | n/a | 10M | -35.9M | 24.1M | 44M | -55.29M | 40.09M |
Investing Cash Flow | 85.41M | 99.7M | 97.43M | 36.33M | 40.85M | -150.67M | -63.72M | -21.19M | -47.65M | 98.26M | -1.8M | 8.34M | -37.26M | 22.49M | 42.19M | -57.61M | 37.85M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 439K | 613K | 674K | 35.19M | 30.4M | 30.23M | 30.18M | 507K | 641K | 648K | 1.14M | 1.25M | 1.49M | 2.5M | 14.84M | 14.9M | 15.76M |
Financial Cash Flow | 7.35M | 7.52M | 5.52M | 35.19M | 30.4M | 30.23M | 30.18M | 507K | 641K | 648K | 1.14M | 1.25M | 1.49M | 110.21M | 122.55M | 122.61M | 123.47M |
Net Cash Flow | 11.53M | 20.99M | 14.66M | -14.29M | -20.17M | -176.48M | -69.01M | -71.75M | -107.13M | -11.88M | -141.25M | -126.86M | -166.18M | 13.67M | 59.47M | -35.24M | 186.38M |
Free Cash Flow | -81.54M | -86.54M | -88.78M | -86.29M | -92.34M | -56.88M | -36.22M | -52.22M | -61.18M | -112.53M | -142.39M | -138.1M | -131.77M | -120.64M | -107.08M | -102.56M | 22.81M |